Hims investors have opportunity to lead hims & hers health, inc. securities fraud lawsuit

New york , aug. 3, 2025 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of common stock of hims & hers health, inc. (nyse: hims) between april 29, 2025 and june 23, 2025, both dates inclusive (the "class period"), of the important august 25, 2025 lead plaintiff deadline. so what: if you purchased hims common stock during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
HIMS Ratings Summary
HIMS Quant Ranking